Chen S - Search Results

1

The membrane complement regulatory protein CD59 promotes tumor growth and predicts poor prognosis in breast cancer.

Ouyang Q, Zhang L, Jiang Y, Ni X, Chen S, Ye F, Du Y, Huang L, Ding P, Wang N, Yang C, Huang T, Sun Y, Li S, Xia Y, Hu W, Luo R, Shao Z. Ouyang Q, et al. Among authors: chen s. Int J Oncol. 2016 May;48(5):2015-24. doi: 10.3892/ijo.2016.3408. Epub 2016 Feb 24. Int J Oncol. 2016. PMID: 26935178

2

[Effects of perioperative enteral immunonutrition on nutritional status, immunity and inflammatory response of elderly patients].

Wang ZD, Peng JS, Chen S, Huang ZM, Huang L. Wang ZD, et al. Among authors: chen s. Zhonghua Yi Xue Za Zhi. 2006 May 30;86(20):1410-3. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16796925 Clinical Trial. Chinese.

3

A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer.

Chen S, Chen CM, Yu KD, Yang WT, Shao ZM. Chen S, et al. Among authors: chen cm. J Surg Oncol. 2012 May;105(6):577-85. doi: 10.1002/jso.22140. Epub 2011 Nov 7. J Surg Oncol. 2012. PMID: 22065549

4

Prognostic value of a positive-to-negative change in hormone receptor status after neoadjuvant chemotherapy in patients with hormone receptor-positive breast cancer.

Chen S, Chen CM, Yu KD, Zhou RJ, Shao ZM. Chen S, et al. Among authors: chen cm. Ann Surg Oncol. 2012 Sep;19(9):3002-11. doi: 10.1245/s10434-012-2318-2. Epub 2012 Mar 22. Ann Surg Oncol. 2012. PMID: 22437200

5

Obesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancer.

Chen S, Chen CM, Zhou Y, Zhou RJ, Yu KD, Shao ZM. Chen S, et al. Among authors: chen cm. PLoS One. 2012;7(7):e41380. doi: 10.1371/journal.pone.0041380. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848477 Free PMC article. Clinical Trial.

6

Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.

Yu KD, Jiang YZ, Chen S, Cao ZG, Wu J, Shen ZZ, Shao ZM. Yu KD, et al. Among authors: chen s. Mayo Clin Proc. 2012 Dec;87(12):1171-80. doi: 10.1016/j.mayocp.2012.07.023. Mayo Clin Proc. 2012. PMID: 23218085 Free PMC article.

7

Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging.

Chen S, Liu Y, Huang L, Chen CM, Wu J, Shao ZM. Chen S, et al. Among authors: chen cm. Ann Surg Oncol. 2014 Jan;21(1):42-50. doi: 10.1245/s10434-013-3245-6. Epub 2013 Sep 7. Ann Surg Oncol. 2014. PMID: 24013900

8

The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.

Chen S, Jiang YZ, Huang L, Zhou RJ, Yu KD, Liu Y, Shao ZM. Chen S, et al. Clin Cancer Res. 2013 Dec 15;19(24):6853-62. doi: 10.1158/1078-0432.CCR-13-1617. Epub 2013 Oct 18. Clin Cancer Res. 2013. PMID: 24141623

9

Prognostic and predictive value of Phospho-p44/42 and pAKT in HER2-positive locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

Huang L, Chen T, Chen C, Chen S, Liu Y, Wu J, Shao Z. Huang L, et al. Among authors: chen c, chen s, chen t. World J Surg Oncol. 2013 Nov 30;11:307. doi: 10.1186/1477-7819-11-307. World J Surg Oncol. 2013. PMID: 24289519 Free PMC article.

10

A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.

Huang L, Liu Z, Chen S, Liu Y, Shao Z. Huang L, et al. Among authors: chen s. PLoS One. 2013 Dec 10;8(12):e83081. doi: 10.1371/journal.pone.0083081. eCollection 2013. PLoS One. 2013. PMID: 24340082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86,477 results

Search Page

Filters